Skip to main content
logo
Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
303.59
+7.67 (2.59%)
At close: Jun 26, 2026, 4:00 PM EDT
303.00
-0.59 (-0.19%)
After-hours: Jun 26, 2026, 5:54 PM EDT

Ligand Pharmaceuticals Market Cap

Ligand Pharmaceuticals has a market cap or net worth of $6.08 billion as of June 26, 2026. Its market cap has increased by 173.28% in one year.

Market Cap
6.08B
Enterprise Value
5.76B
1-Year Change
173.28%
Ranking
#1275
Category
Mid-Cap
Stock Price
$303.59

Market Cap Chart

Since December 1, 1998, Ligand Pharmaceuticals's market cap has increased from $430.80M to $6.08B, an increase of 1,312.32%. That is a compound annual growth rate of 10.07%.

History

DateMarket Cap% Change
Jun 26, 20266.08B63.50%
Dec 31, 20253.72B83.80%
Dec 31, 20242.02B62.58%
Dec 29, 20231.25B10.35%
Dec 30, 20221.13B-56.28%
Dec 31, 20212.58B61.30%
Dec 31, 20201.60B-12.63%
Dec 31, 20191.83B-36.49%
Dec 31, 20182.88B-0.20%
Dec 29, 20172.89B36.08%
Dec 30, 20162.12B-1.70%
Dec 31, 20152.16B102.78%
Dec 31, 20141.07B-0.76%
Dec 31, 20131.07B159.26%
Dec 31, 2012414.10M77.34%
Dec 30, 2011233.50M33.50%
Dec 31, 2010174.90M-28.67%
Dec 31, 2009245.20M-5.73%
Dec 31, 2008260.10M-43.57%
Dec 31, 2007460.90M-46.88%
Dec 29, 2006867.60M4.96%
Dec 30, 2005826.60M-3.95%
Dec 31, 2004860.60M-19.85%
Dec 31, 20031.07B179.68%
Dec 31, 2002383.90M-64.11%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
PTC Therapeutics7.01B
Cogent Biosciences6.50B
Scholar Rock Holding6.45B
CG Oncology6.42B
Belite Bio5.89B
Travere Therapeutics5.49B
Xenon Pharmaceuticals5.49B
Caris Life Sciences5.29B
Market Cap Rankings